Abstract
摘要
相似文献
1
Influenza vaccination cost effective in U.S. adults.
Geriatrics. 2006 Feb;61(2):14.
2
Vaccine cost-effective, but underused.
Nurs Manage. 2002 Oct;33(10):10.
3
The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.
4
Cost-effectiveness of influenza vaccination in working-age cancer patients.
Cancer. 2007 Jun 1;109(11):2357-64. doi: 10.1002/cncr.22670.
5
The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Vaccine. 2007 Sep 28;25(39-40):6900-10. doi: 10.1016/j.vaccine.2007.07.033. Epub 2007 Aug 6.
6
Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
Am J Prev Med. 2006 Jul;31(1):72-9. doi: 10.1016/j.amepre.2006.03.008.
7
[Cost-effectiveness of prophylaxis and treatment of influenza].
Dtsch Med Wochenschr. 2003 Oct 24;128(43):2267-70. doi: 10.1055/s-2003-43100.
8
[Pharmaco-economics of anti-influenza vaccinations].
Pol Merkur Lekarski. 2003 Jun;14(84):679-81.
9
[Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)].
Med Clin (Barc). 1990 May 26;94(20):777-81.
10
Employees' willingness to pay to prevent influenza.
Am J Manag Care. 2010 Aug;16(8):e205-14.
Zotero 插件